Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 852 participants.
Also called NCT07609654
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 852 participants
- Registry
-
NCT07609654
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07609654. Randomized; single masking; primary purpose treatment. Start 2026-10-26 (anticipated); primary completion 2031-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
- Acronym
- OASIS-AF
- Condition
- Intracerebral Hemorrhage
- Condition
- Atrial Fibrillation (AF)
- Condition
- Ischemia Stroke
- Intervention (Drug)
- Apixaban
- Intervention (Other)
- No Oral Anticoagulation Strategy
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct07609654- Content hash
45bac8d245f138d5a7bd439613264fe8942f51087df73278e408709ded9db28b